Table 1. Concomitant and sequential sampling of GPs and PLGA nanoparticles by DN DCs.
GP-GP | GP-PLGA | |||||||||||
Togethera | 1 hr apart | Together | 1 hr apart | |||||||||
P1 | P2 | Both | P1 | P2 | Both | P1 | P2 | Both | P1 | P2 | Both | |
PP | 65±3 | 64±6 | 62±6 | 43±8 | 53±3 | 40±6 | 39±1 | 39±0 | 39±1 | 47±6 | 52±5 | 41±6 |
MLN | 90±2 | 91±2 | 90±2 | 43±7 | 52±4 | 42±4 | 70±4 | 73±2 | 70±3 | 35±4 | 38±2 | 35±2 |
P1, first particle; P2, second particle. Particles were administered to mice by gavage as a 1∶1 mixture (“together”) or serially “1 hr apart”. PP and MLN were collected 24 hr later, cryosectioned and viewed by confocal microscopy. Values indicate the average number (± standard deviation) of particle-containing DCs per PP, based on four mice per group and six sections per mouse.